SynthesisBMJ open2015
Clinical practice guidelines for hypertension in China: a systematic review of the methodological quality.
Synthesis in BMJ open, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Improvement of Clinical Practice Guideline Appraisal by Human Experts and AI Agents by Using Structured Guidance: Systematic Review, Meta-Analysis, and Validation Study.Journal of medical Internet research · 2026Pooled it
- Quality assessment of clinical practice guidelines for chronic kidney disease: a systematic review.BMC nephrology · 2019Pooled it
- Inverse association between cardiometabolic index and endometriosis in women of reproductive age: A cross-sectional, population-based study.The Journal of international medical research · 2026Article
- Study of the interaction between cardiometabolic index and inflammatory index on the risk of prostate cancer development.Frontiers in immunology · 2025Article
- The relationship between skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease subtypes in middle-aged and elderly population: a single-center retrospective study.Frontiers in nutrition · 2023Article
- Adherence Behaviors and Related Factors Among Elderly Hypertensive Patients in China: Evidence from the China Health and Retirement Longitudinal Study.Patient preference and adherence · 2023Article
- Sex-Specific Contribution of Cardiometabolic Index in Predicting Metabolic Dysfunction-Associated Fatty Liver Disease: Insights from a General Population.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023Article
- Exploration of Stratified Evidence Scoring Method of Acupuncture Clinical Practice Guidelines.Chinese journal of integrative medicine · 2021Article
- Management in the paediatric wards facing novel coronavirus infection: a rapid review of guidelines and consensuses.BMJ open · 2020Review
- Hyperglycemia is associated with poor in-hospital outcome in elderly patients with acute ischemic stroke.Medicine · 2019Observational
- Assessing the quality of guidelines for primary aldosteronism: which guidelines are worth applying in diverse settings?Journal of hypertension · 2019Review
- Risk factors for hypertensive retinopathy in a Chinese population with hypertension: The Beijing Eye study.Experimental and therapeutic medicine · 2019Article
- Prevalence of hypertension and hypertension control rates among elderly adults during the cold season in rural Northeast China: a cross-sectional study.Journal of rural medicine : JRM · 2018Article
- Clinical practice guidelines in China.BMJ (Clinical research ed.) · 2018Article
- Methodological quality and transparency of clinical practice guidelines for the pharmacological treatment of non-communicable diseases using the AGREE II instrument: a systematic review protocol.Systematic reviews · 2017Article
- Using guidelines to improve neonatal health in China and Vietnam: a qualitative study.BMC health services research · 2016Article
- Non-Communicable Disease Clinical Practice Guidelines in Brazil: A Systematic Assessment of Methodological Quality and Transparency.PloS one · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveClinical practice guidelines (CPGs) provide clinicians with specific recommendations for practice, but due to the increasing number of CPGs developed by diverse organisations over the past few years, there are concerns about the quality of some CPGs. This paper proposes a systematic review of the methodological quality of the CPGs for hypertension that were developed in China.
designA systematic review of CPGs for the management of hypertension in adult patients in China. DATA RESOURCES: Chinese electronic databases, Chinese guideline websites and Google Scholar were searched, and the reference lists of relevant publications were also screened for additional information. CPGs for the management of hypertension in adult patients were identified. The main characteristics of the CPGs were extracted, and the scaled Appraisal of Guidelines, REsearch and Evaluation II (AGREE II) domain percentages were independently evaluated by two reviewers.
resultsA total of 17 CPGs, with publication dates ranging from 2001 to 2011, were identified. There was considerable variation in the quality of the CPGs across the AGREE II domains. Overall, the domains of 'rigor of development' and 'editorial independence' were poorly addressed, with an average score of 18% and 16%, respectively. Also less well addressed were the 'stakeholder involvement' and 'applicability' domains, for which the average domain scores were 28% and 20%, respectively. The CPGs performance was less problematic in the domains of 'scope and purpose' and 'clarity and presentation', with a median of 41% for both. After considering the domain scores, 8 CPGs could be recommended with modification for use.
conclusionsThere is considerable room for improvement of the methodological quality of CPGs for hypertension in China. Greater efforts should to be devoted to ensure the explicit and transparent reporting of potential conflicts of interest of stakeholders, and to consider the quality of the evidence and grade recommendations in the CPG development process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.